If we take a look at MSD’s international presence, the group has grown into the third largest pharma company in the world. Here in South Africa,…

Mr. Daniel, after working with Pfizer Australia, working in Hong Kong as Regional Marketing Director for the Asian operation and in Japan, you have…

Ms Joubert, could you start by telling our readers over the 16 months of heading the operations here, what have been the most challenging situations…

Since we interviewed you in 2005, there have been many changes in the market, from consolidation, an increasing generic penetration, to new healthcare…

We interviewed Graham Somerville in 2004, the year when IHD, formerly jointly owned by 11 major pharmaceutical companies, was acquired by UTi. We are…

The South African affiliate was established in June 2003. Could you come back on the main milestones in the company’s development from 2003…

Mr. Ehsan, you are the General Manager of IMS Africa since January 2010. What is the strategic importance of South Africa for IMS Global and for your…

Mrs. Reid, how would you define and describe the generic part of the South African pharmaceutical market? Linda Reid: South Africa is very much a…

Ms Beaumont, can you describe the association to our readers and its main objectives? Innovative Medicines South Africa (IMSA) represents…